Three Mitogen-Activated Protein Kinases Inhibit Insulin Signaling by Different Mechanisms in 3T3-L1 Adipocytes

Autor: Tomoichiro Asano, Yukiko Onishi, Motonobu Anai, Miho Abe, Yoshitomo Oka, Takehide Ogihara, Hideyuki Sakoda, Midori Fujishiro, Yasushi Fukushima, Yukiko Gotoh, Hideki Katagiri, Nobuhiro Shojima, Hiraku Ono, Masatoshi Kikuchi
Rok vydání: 2003
Předmět:
MAPK/ERK pathway
medicine.medical_specialty
Insulin Receptor Substrate Proteins
Blotting
Western

MAP Kinase Kinase 1
MAP Kinase Kinase 7
MAP Kinase Kinase 6
Protein Serine-Threonine Kinases
Mitogen-activated protein kinase kinase
Gene Expression Regulation
Enzymologic

Mice
Phosphatidylinositol 3-Kinases
chemistry.chemical_compound
Endocrinology
Transduction
Genetic

Insulin receptor substrate
Internal medicine
Adipocytes
medicine
Animals
Insulin
Phosphorylation
Molecular Biology
Phosphoinositide-3 Kinase Inhibitors
Mitogen-Activated Protein Kinase Kinases
biology
Tumor Necrosis Factor-alpha
GRB10
Intracellular Signaling Peptides and Proteins
Tyrosine phosphorylation
3T3 Cells
General Medicine
Phosphoproteins
Precipitin Tests
IRS2
Cell biology
Insulin receptor
Glucose
chemistry
Calcium-Calmodulin-Dependent Protein Kinases
Mutagenesis
Site-Directed

biology.protein
Insulin Resistance
Mitogen-Activated Protein Kinases
Signal Transduction
Zdroj: Molecular Endocrinology. 17:487-497
ISSN: 1944-9917
0888-8809
DOI: 10.1210/me.2002-0131
Popis: TNFα, which activates three different MAPKs [ERK, p38, and jun amino terminal kinase (JNK)], also induces insulin resistance. To better understand the respective roles of these three MAPK pathways in insulin signaling and their contribution to insulin resistance, constitutively active MAPK/ERK kinase (MEK)1, MAPK kinase (MKK6), and MKK7 mutants were overexpressed in 3T3-L1 adipocytes using an adenovirus-mediated transfection procedure. The MEK1 mutant, which activates ERK, markedly down-regulated expression of the insulin receptor (IR) and its major substrates, IRS-1 and IRS-2, mRNA and protein, and in turn reduced tyrosine phosphorylation of IR as well as IRS-1 and IRS-2 and their associated phosphatidyl inositol 3-kinase (PI3K) activity. The MKK6 mutant, which activates p38, moderately inhibited IRS-1 and IRS-2 expressions and IRS-1-associated PI3K activity without exerting a significant effect on the IR. Finally, the MKK7 mutant, which activates JNK, reduced tyrosine phosphorylation of IRS-1 and IRS-2 and IRS-associated PI3K activity without affecting expression of the IR, IRS-1, or IRS-2. In the context of our earlier report showing down-regulation of glucose transporter 4 by MEK1-ERK and MKK6/3-p38, the present findings suggest that chronic activation of ERK, p38, or JNK can induce insulin resistance by affecting glucose transporter expression and insulin signaling, though via distinctly different mechanisms. The contribution of ERK is, however, the strongest.
Databáze: OpenAIRE